Levopidon 40 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 40 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 40 mg

Levopidon 45 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 45 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 45 mg

Levopidon 50 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 50 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 50 mg

Levopidon 55 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 55 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 55 mg

Levopidon 5 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 5 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 5 mg

Levopidon 60 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 60 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 60 mg

Levopidon 65 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 65 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 65 mg

Levopidon 70 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 70 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 70 mg

Levopidon 75 mg oral opløsning, enkeltdosisbeholder Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levopidon 75 mg oral opløsning, enkeltdosisbeholder

dne pharma as - levomethadonhydrochlorid - oral opløsning, enkeltdosisbeholder - 75 mg

Verzenios Den Europæiske Union - dansk - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - bryst neoplasmer - antineoplastiske midler - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.